NCT00117468View on ClinicalTrials.gov

Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Infertility

Interventions

DRUG

DR-2011

Administered vaginally from Day 14 to Day 31

DRUG

Progesterone 8% Vaginal Gel

Administered vaginally from Cycle Day 14 to Day 31

Trial Locations (1)

23507

Duramed Investigational Site, Norfolk

Sponsors

Lead Sponsor

Duramed Research

All Listed Sponsors

lead

Duramed Research

INDUSTRY